MEI Pharma director was just granted 50,000 options

Kevan Clemens, a director of MEI Pharma, just received 50,000 options from the company. The strike price of the options received was $2.95, and these expire on July 01, 2031. Clemens now owns at least 50,000 options on the company.

Some additional info was provided as follows:

The options will vest in equal monthly installments over twelve months.
All of such options are presently exercisable.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever MEI Pharma makes a similar move, sign up!

Auto Refresh